nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Foetor hepaticus—Ezetimibe—atherosclerosis	0.02	0.0238	CcSEcCtD
Carbimazole—Myopathy—Rosuvastatin—atherosclerosis	0.0195	0.0232	CcSEcCtD
Carbimazole—Foetor hepaticus—Simvastatin—atherosclerosis	0.0191	0.0227	CcSEcCtD
Carbimazole—Foetor hepaticus—Pravastatin—atherosclerosis	0.0173	0.0205	CcSEcCtD
Carbimazole—Liver disorder—Ezetimibe—atherosclerosis	0.0167	0.0198	CcSEcCtD
Carbimazole—Myopathy—Lovastatin—atherosclerosis	0.0165	0.0196	CcSEcCtD
Carbimazole—Myopathy—Ezetimibe—atherosclerosis	0.0162	0.0193	CcSEcCtD
Carbimazole—Liver disorder—Simvastatin—atherosclerosis	0.0159	0.0189	CcSEcCtD
Carbimazole—Myopathy—Simvastatin—atherosclerosis	0.0155	0.0184	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—CSF1R—atherosclerosis	0.0145	0.0921	CbGpPWpGaD
Carbimazole—Liver disorder—Pravastatin—atherosclerosis	0.0144	0.0171	CcSEcCtD
Carbimazole—Myopathy—Niacin—atherosclerosis	0.0142	0.0169	CcSEcCtD
Carbimazole—Myopathy—Pravastatin—atherosclerosis	0.014	0.0166	CcSEcCtD
Carbimazole—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0132	0.0157	CcSEcCtD
Carbimazole—Jaundice cholestatic—Simvastatin—atherosclerosis	0.0123	0.0147	CcSEcCtD
Carbimazole—Hepatocellular injury—Ezetimibe—atherosclerosis	0.0114	0.0135	CcSEcCtD
Carbimazole—Jaundice cholestatic—Niacin—atherosclerosis	0.0113	0.0135	CcSEcCtD
Carbimazole—Jaundice cholestatic—Pravastatin—atherosclerosis	0.0112	0.0133	CcSEcCtD
Carbimazole—Hepatocellular injury—Simvastatin—atherosclerosis	0.0108	0.0129	CcSEcCtD
Carbimazole—Hepatocellular injury—Pravastatin—atherosclerosis	0.0098	0.0116	CcSEcCtD
Carbimazole—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00932	0.0111	CcSEcCtD
Carbimazole—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00872	0.0104	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP7A1—atherosclerosis	0.00812	0.0514	CbGpPWpGaD
Carbimazole—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00788	0.00936	CcSEcCtD
Carbimazole—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00762	0.00905	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP27A1—atherosclerosis	0.00751	0.0475	CbGpPWpGaD
Carbimazole—Jaundice—Rosuvastatin—atherosclerosis	0.00746	0.00886	CcSEcCtD
Carbimazole—Eosinophilia—Lovastatin—atherosclerosis	0.0072	0.00855	CcSEcCtD
Carbimazole—Eosinophilia—Ezetimibe—atherosclerosis	0.00706	0.00839	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—GJA4—atherosclerosis	0.00688	0.0435	CbGpPWpGaD
Carbimazole—Hepatitis—Rosuvastatin—atherosclerosis	0.00687	0.00816	CcSEcCtD
Carbimazole—Eosinophilia—Simvastatin—atherosclerosis	0.00674	0.008	CcSEcCtD
Carbimazole—Liver function test abnormal—Niacin—atherosclerosis	0.00667	0.00792	CcSEcCtD
Carbimazole—Liver function test abnormal—Pravastatin—atherosclerosis	0.00657	0.0078	CcSEcCtD
Carbimazole—Jaundice—Ezetimibe—atherosclerosis	0.0062	0.00736	CcSEcCtD
Carbimazole—Eosinophilia—Pravastatin—atherosclerosis	0.00609	0.00723	CcSEcCtD
Carbimazole—Jaundice—Simvastatin—atherosclerosis	0.00591	0.00702	CcSEcCtD
Carbimazole—Hepatitis—Lovastatin—atherosclerosis	0.00582	0.00691	CcSEcCtD
Carbimazole—Hepatitis—Ezetimibe—atherosclerosis	0.00571	0.00678	CcSEcCtD
Carbimazole—Angioedema—Rosuvastatin—atherosclerosis	0.00546	0.00649	CcSEcCtD
Carbimazole—Hepatitis—Simvastatin—atherosclerosis	0.00545	0.00647	CcSEcCtD
Carbimazole—Jaundice—Niacin—atherosclerosis	0.00543	0.00645	CcSEcCtD
Carbimazole—Stomatitis—Niacin—atherosclerosis	0.00543	0.00645	CcSEcCtD
Carbimazole—Jaundice—Pravastatin—atherosclerosis	0.00535	0.00635	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—PDGFB—atherosclerosis	0.00525	0.0333	CbGpPWpGaD
Carbimazole—Angiopathy—Ezetimibe—atherosclerosis	0.00518	0.00615	CcSEcCtD
Carbimazole—Alopecia—Lovastatin—atherosclerosis	0.00514	0.00611	CcSEcCtD
Carbimazole—Arthralgia—Rosuvastatin—atherosclerosis	0.00509	0.00605	CcSEcCtD
Carbimazole—Myalgia—Rosuvastatin—atherosclerosis	0.00509	0.00605	CcSEcCtD
Carbimazole—Alopecia—Ezetimibe—atherosclerosis	0.00505	0.00599	CcSEcCtD
Carbimazole—Haemoglobin—Niacin—atherosclerosis	0.00503	0.00597	CcSEcCtD
Carbimazole—Haemorrhage—Niacin—atherosclerosis	0.005	0.00594	CcSEcCtD
Carbimazole—Hepatitis—Niacin—atherosclerosis	0.005	0.00594	CcSEcCtD
Carbimazole—Hepatitis—Pravastatin—atherosclerosis	0.00492	0.00585	CcSEcCtD
Carbimazole—Infection—Rosuvastatin—atherosclerosis	0.00485	0.00576	CcSEcCtD
Carbimazole—Alopecia—Simvastatin—atherosclerosis	0.00481	0.00571	CcSEcCtD
Carbimazole—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00479	0.00568	CcSEcCtD
Carbimazole—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00478	0.00568	CcSEcCtD
Carbimazole—Ill-defined disorder—Lovastatin—atherosclerosis	0.0047	0.00558	CcSEcCtD
Carbimazole—Angioedema—Lovastatin—atherosclerosis	0.00463	0.0055	CcSEcCtD
Carbimazole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00461	0.00548	CcSEcCtD
Carbimazole—Malaise—Lovastatin—atherosclerosis	0.00457	0.00543	CcSEcCtD
Carbimazole—Angioedema—Ezetimibe—atherosclerosis	0.00454	0.00539	CcSEcCtD
Carbimazole—Angiopathy—Niacin—atherosclerosis	0.00454	0.00539	CcSEcCtD
Carbimazole—Leukopenia—Lovastatin—atherosclerosis	0.00454	0.00539	CcSEcCtD
Carbimazole—Malaise—Ezetimibe—atherosclerosis	0.00448	0.00532	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00445	0.00528	CcSEcCtD
Carbimazole—Alopecia—Niacin—atherosclerosis	0.00442	0.00525	CcSEcCtD
Carbimazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.0044	0.00522	CcSEcCtD
Carbimazole—Alopecia—Pravastatin—atherosclerosis	0.00435	0.00517	CcSEcCtD
Carbimazole—Angioedema—Simvastatin—atherosclerosis	0.00433	0.00514	CcSEcCtD
Carbimazole—Arthralgia—Lovastatin—atherosclerosis	0.00431	0.00512	CcSEcCtD
Carbimazole—Myalgia—Lovastatin—atherosclerosis	0.00431	0.00512	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—INS—atherosclerosis	0.00429	0.0272	CbGpPWpGaD
Carbimazole—Malaise—Simvastatin—atherosclerosis	0.00427	0.00508	CcSEcCtD
Carbimazole—Discomfort—Lovastatin—atherosclerosis	0.00426	0.00506	CcSEcCtD
Carbimazole—Leukopenia—Simvastatin—atherosclerosis	0.00424	0.00504	CcSEcCtD
Carbimazole—Myalgia—Ezetimibe—atherosclerosis	0.00423	0.00503	CcSEcCtD
Carbimazole—Arthralgia—Ezetimibe—atherosclerosis	0.00423	0.00503	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0042	0.00499	CcSEcCtD
Carbimazole—Discomfort—Ezetimibe—atherosclerosis	0.00418	0.00497	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—IGF1—atherosclerosis	0.00415	0.0263	CbGpPWpGaD
Carbimazole—Infection—Lovastatin—atherosclerosis	0.00411	0.00488	CcSEcCtD
Carbimazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.00405	0.00481	CcSEcCtD
Carbimazole—Arthralgia—Simvastatin—atherosclerosis	0.00404	0.00479	CcSEcCtD
Carbimazole—Myalgia—Simvastatin—atherosclerosis	0.00404	0.00479	CcSEcCtD
Carbimazole—Infection—Ezetimibe—atherosclerosis	0.00403	0.00479	CcSEcCtD
Carbimazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00402	0.00478	CcSEcCtD
Carbimazole—Discomfort—Simvastatin—atherosclerosis	0.00399	0.00474	CcSEcCtD
Carbimazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.00398	0.00472	CcSEcCtD
Carbimazole—Angioedema—Niacin—atherosclerosis	0.00398	0.00472	CcSEcCtD
Carbimazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.00398	0.00472	CcSEcCtD
Carbimazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00397	0.00472	CcSEcCtD
Carbimazole—Skin disorder—Ezetimibe—atherosclerosis	0.00394	0.00468	CcSEcCtD
Carbimazole—Angioedema—Pravastatin—atherosclerosis	0.00392	0.00465	CcSEcCtD
Carbimazole—Leukopenia—Niacin—atherosclerosis	0.0039	0.00463	CcSEcCtD
Carbimazole—Urticaria—Rosuvastatin—atherosclerosis	0.00388	0.0046	CcSEcCtD
Carbimazole—Malaise—Pravastatin—atherosclerosis	0.00386	0.00459	CcSEcCtD
Carbimazole—Infection—Simvastatin—atherosclerosis	0.00384	0.00456	CcSEcCtD
Carbimazole—Leukopenia—Pravastatin—atherosclerosis	0.00384	0.00456	CcSEcCtD
Carbimazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.00379	0.0045	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00377	0.0239	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00377	0.00448	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00372	0.0236	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—atherosclerosis	0.00371	0.0235	CbGpPWpGaD
Carbimazole—Arthralgia—Niacin—atherosclerosis	0.00371	0.0044	CcSEcCtD
Carbimazole—Myalgia—Niacin—atherosclerosis	0.00371	0.0044	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0037	0.00439	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00368	0.00437	CcSEcCtD
Carbimazole—Myalgia—Pravastatin—atherosclerosis	0.00365	0.00433	CcSEcCtD
Carbimazole—Arthralgia—Pravastatin—atherosclerosis	0.00365	0.00433	CcSEcCtD
Carbimazole—Discomfort—Pravastatin—atherosclerosis	0.0036	0.00428	CcSEcCtD
Carbimazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0036	0.00427	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00352	0.00419	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00349	0.0221	CbGpPWpGaD
Carbimazole—Infection—Pravastatin—atherosclerosis	0.00347	0.00413	CcSEcCtD
Carbimazole—Pruritus—Rosuvastatin—atherosclerosis	0.00345	0.0041	CcSEcCtD
Carbimazole—Skin disorder—Niacin—atherosclerosis	0.00345	0.0041	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00344	0.0218	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.00342	0.00407	CcSEcCtD
Carbimazole—Feeling abnormal—Lovastatin—atherosclerosis	0.00341	0.00405	CcSEcCtD
Carbimazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.00334	0.00397	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ESR2—atherosclerosis	0.00333	0.0211	CbGpPWpGaD
Carbimazole—Urticaria—Lovastatin—atherosclerosis	0.00329	0.0039	CcSEcCtD
Carbimazole—Body temperature increased—Lovastatin—atherosclerosis	0.00327	0.00388	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00324	0.00384	CcSEcCtD
Carbimazole—Urticaria—Ezetimibe—atherosclerosis	0.00322	0.00383	CcSEcCtD
Carbimazole—Body temperature increased—Ezetimibe—atherosclerosis	0.00321	0.00381	CcSEcCtD
Carbimazole—Feeling abnormal—Simvastatin—atherosclerosis	0.00319	0.00379	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00319	0.00378	CcSEcCtD
Carbimazole—Rash—Rosuvastatin—atherosclerosis	0.00308	0.00365	CcSEcCtD
Carbimazole—Dermatitis—Rosuvastatin—atherosclerosis	0.00307	0.00365	CcSEcCtD
Carbimazole—Urticaria—Simvastatin—atherosclerosis	0.00307	0.00365	CcSEcCtD
Carbimazole—Body temperature increased—Simvastatin—atherosclerosis	0.00306	0.00363	CcSEcCtD
Carbimazole—Headache—Rosuvastatin—atherosclerosis	0.00306	0.00363	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00306	0.0194	CbGpPWpGaD
Carbimazole—Hypersensitivity—Lovastatin—atherosclerosis	0.00305	0.00362	CcSEcCtD
Carbimazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.00299	0.00355	CcSEcCtD
Carbimazole—Pruritus—Lovastatin—atherosclerosis	0.00293	0.00348	CcSEcCtD
Carbimazole—Nausea—Rosuvastatin—atherosclerosis	0.0029	0.00344	CcSEcCtD
Carbimazole—Feeling abnormal—Pravastatin—atherosclerosis	0.00288	0.00342	CcSEcCtD
Carbimazole—Pruritus—Ezetimibe—atherosclerosis	0.00287	0.00341	CcSEcCtD
Carbimazole—Hypersensitivity—Simvastatin—atherosclerosis	0.00285	0.00339	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00283	0.0179	CbGpPWpGaD
Carbimazole—Urticaria—Niacin—atherosclerosis	0.00282	0.00335	CcSEcCtD
Carbimazole—Body temperature increased—Niacin—atherosclerosis	0.00281	0.00334	CcSEcCtD
Carbimazole—Urticaria—Pravastatin—atherosclerosis	0.00278	0.0033	CcSEcCtD
Carbimazole—Body temperature increased—Pravastatin—atherosclerosis	0.00276	0.00328	CcSEcCtD
Carbimazole—Pruritus—Simvastatin—atherosclerosis	0.00274	0.00325	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—VEGFA—atherosclerosis	0.00271	0.0172	CbGpPWpGaD
Carbimazole—Hypersensitivity—Niacin—atherosclerosis	0.00262	0.00311	CcSEcCtD
Carbimazole—Rash—Lovastatin—atherosclerosis	0.00261	0.0031	CcSEcCtD
Carbimazole—Dermatitis—Lovastatin—atherosclerosis	0.00261	0.00309	CcSEcCtD
Carbimazole—Headache—Lovastatin—atherosclerosis	0.00259	0.00308	CcSEcCtD
Carbimazole—Hypersensitivity—Pravastatin—atherosclerosis	0.00258	0.00306	CcSEcCtD
Carbimazole—Rash—Ezetimibe—atherosclerosis	0.00256	0.00304	CcSEcCtD
Carbimazole—Dermatitis—Ezetimibe—atherosclerosis	0.00256	0.00303	CcSEcCtD
Carbimazole—Headache—Ezetimibe—atherosclerosis	0.00254	0.00302	CcSEcCtD
Carbimazole—Pruritus—Niacin—atherosclerosis	0.00251	0.00298	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—TGFB1—atherosclerosis	0.00249	0.0158	CbGpPWpGaD
Carbimazole—Pruritus—Pravastatin—atherosclerosis	0.00247	0.00294	CcSEcCtD
Carbimazole—Nausea—Lovastatin—atherosclerosis	0.00246	0.00292	CcSEcCtD
Carbimazole—Rash—Simvastatin—atherosclerosis	0.00244	0.0029	CcSEcCtD
Carbimazole—Dermatitis—Simvastatin—atherosclerosis	0.00244	0.00289	CcSEcCtD
Carbimazole—Headache—Simvastatin—atherosclerosis	0.00242	0.00288	CcSEcCtD
Carbimazole—Nausea—Ezetimibe—atherosclerosis	0.00241	0.00286	CcSEcCtD
Carbimazole—Nausea—Simvastatin—atherosclerosis	0.0023	0.00273	CcSEcCtD
Carbimazole—Rash—Niacin—atherosclerosis	0.00224	0.00266	CcSEcCtD
Carbimazole—Dermatitis—Niacin—atherosclerosis	0.00224	0.00266	CcSEcCtD
Carbimazole—Headache—Niacin—atherosclerosis	0.00223	0.00264	CcSEcCtD
Carbimazole—Rash—Pravastatin—atherosclerosis	0.00221	0.00262	CcSEcCtD
Carbimazole—Dermatitis—Pravastatin—atherosclerosis	0.0022	0.00262	CcSEcCtD
Carbimazole—Headache—Pravastatin—atherosclerosis	0.00219	0.0026	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—atherosclerosis	0.00217	0.0137	CbGpPWpGaD
Carbimazole—Nausea—Niacin—atherosclerosis	0.00211	0.00251	CcSEcCtD
Carbimazole—Nausea—Pravastatin—atherosclerosis	0.00208	0.00247	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—IL6—atherosclerosis	0.00188	0.0119	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP7A1—atherosclerosis	0.00162	0.0103	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.0016	0.0101	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LDLRAP1—atherosclerosis	0.00156	0.00987	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP27A1—atherosclerosis	0.0015	0.0095	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00148	0.00937	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLTP—atherosclerosis	0.00147	0.00928	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.00138	0.00872	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LTA4H—atherosclerosis	0.00127	0.00805	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG8—atherosclerosis	0.00127	0.00805	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—atherosclerosis	0.00124	0.00784	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00107	0.00676	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.00104	0.00661	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG1—atherosclerosis	0.00101	0.00636	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.001	0.00635	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FABP4—atherosclerosis	0.000945	0.00598	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LCAT—atherosclerosis	0.000945	0.00598	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA4—atherosclerosis	0.000928	0.00587	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP7A1—atherosclerosis	0.000911	0.00577	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00087	0.00551	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00087	0.00551	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP27A1—atherosclerosis	0.000842	0.00533	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—atherosclerosis	0.000836	0.00529	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA2—atherosclerosis	0.000798	0.00506	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLA2G2A—atherosclerosis	0.000798	0.00506	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALOX5AP—atherosclerosis	0.000798	0.00506	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALOX15—atherosclerosis	0.000798	0.00506	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG5—atherosclerosis	0.000789	0.00499	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000776	0.00491	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LPA—atherosclerosis	0.000762	0.00482	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BGN—atherosclerosis	0.000738	0.00467	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA5—atherosclerosis	0.00073	0.00462	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLA2G1B—atherosclerosis	0.000703	0.00445	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000688	0.00435	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALOX5—atherosclerosis	0.000679	0.0043	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—atherosclerosis	0.00067	0.00424	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000661	0.00419	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000647	0.00409	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000647	0.00409	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000635	0.00402	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000633	0.00401	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000624	0.00395	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NAMPT—atherosclerosis	0.000609	0.00386	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LIPC—atherosclerosis	0.000605	0.00383	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOC3—atherosclerosis	0.000601	0.00381	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LDLR—atherosclerosis	0.000598	0.00378	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000585	0.0037	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CETP—atherosclerosis	0.000584	0.0037	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000576	0.00365	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SCARB1—atherosclerosis	0.000559	0.00354	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000546	0.00346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000546	0.00346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000546	0.00346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000546	0.00346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00054	0.00342	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMGCR—atherosclerosis	0.000528	0.00334	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000521	0.0033	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.0005	0.00316	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000481	0.00305	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LDLRAP1—atherosclerosis	0.000475	0.00301	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCA1—atherosclerosis	0.000471	0.00298	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000465	0.00294	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLTP—atherosclerosis	0.000447	0.00283	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000414	0.00262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000412	0.00261	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000409	0.00259	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—atherosclerosis	0.000404	0.00256	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.0004	0.00253	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LTA4H—atherosclerosis	0.000388	0.00245	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG8—atherosclerosis	0.000388	0.00245	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOB—atherosclerosis	0.000387	0.00245	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000383	0.00242	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—atherosclerosis	0.000376	0.00238	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LPL—atherosclerosis	0.000369	0.00234	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000364	0.0023	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000361	0.00229	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—atherosclerosis	0.00036	0.00228	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CD36—atherosclerosis	0.000351	0.00222	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—atherosclerosis	0.000332	0.0021	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.00033	0.00209	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARA—atherosclerosis	0.000326	0.00207	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000322	0.00204	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AGT—atherosclerosis	0.000316	0.002	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—atherosclerosis	0.00031	0.00196	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAV1—atherosclerosis	0.000307	0.00194	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG1—atherosclerosis	0.000306	0.00194	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA1—atherosclerosis	0.000306	0.00194	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FABP4—atherosclerosis	0.000288	0.00182	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LCAT—atherosclerosis	0.000288	0.00182	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA4—atherosclerosis	0.000283	0.00179	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—atherosclerosis	0.000279	0.00177	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP7A1—atherosclerosis	0.000278	0.00176	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—atherosclerosis	0.00027	0.00171	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000265	0.00168	CbGpPWpGaD
Carbimazole—TPO—Metabolism—INS—atherosclerosis	0.000264	0.00167	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP27A1—atherosclerosis	0.000257	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000253	0.0016	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000247	0.00156	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALOX15—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA2—atherosclerosis	0.000243	0.00154	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—atherosclerosis	0.000242	0.00153	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG5—atherosclerosis	0.00024	0.00152	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.00024	0.00152	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LPA—atherosclerosis	0.000232	0.00147	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—atherosclerosis	0.000232	0.00147	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BGN—atherosclerosis	0.000225	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000223	0.00141	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA5—atherosclerosis	0.000223	0.00141	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000216	0.00137	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	0.000214	0.00136	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—atherosclerosis	0.000212	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000212	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.000211	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.00021	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000209	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALOX5—atherosclerosis	0.000207	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000191	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAMPT—atherosclerosis	0.000186	0.00118	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000185	0.00117	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LIPC—atherosclerosis	0.000184	0.00117	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOC3—atherosclerosis	0.000183	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LDLR—atherosclerosis	0.000182	0.00115	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CETP—atherosclerosis	0.000178	0.00113	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SCARB1—atherosclerosis	0.00017	0.00108	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000166	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMGCR—atherosclerosis	0.000161	0.00102	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000145	0.000919	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCA1—atherosclerosis	0.000143	0.000908	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—atherosclerosis	0.000123	0.000779	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOB—atherosclerosis	0.000118	0.000746	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—atherosclerosis	0.000115	0.000726	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LPL—atherosclerosis	0.000113	0.000713	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—atherosclerosis	0.00011	0.000695	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CD36—atherosclerosis	0.000107	0.000677	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—atherosclerosis	0.000107	0.000675	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—atherosclerosis	0.000101	0.000642	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARA—atherosclerosis	9.94e-05	0.000629	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AGT—atherosclerosis	9.63e-05	0.00061	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—atherosclerosis	9.43e-05	0.000597	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAV1—atherosclerosis	9.35e-05	0.000592	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA1—atherosclerosis	9.33e-05	0.00059	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—atherosclerosis	8.51e-05	0.000539	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—atherosclerosis	8.22e-05	0.00052	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—INS—atherosclerosis	8.06e-05	0.00051	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—atherosclerosis	7.39e-05	0.000468	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—atherosclerosis	7.07e-05	0.000447	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—atherosclerosis	6.46e-05	0.000409	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—atherosclerosis	3.25e-05	0.000206	CbGpPWpGaD
